These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 15631316

  • 1. The non-invasive diagnosis of precancerous changes of stomach mucosa.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB, Mernova VP.
    Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
    [Abstract] [Full Text] [Related]

  • 2. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Chabannaya TA.
    Rocz Akad Med Bialymst; 2005; 50():183-7. PubMed ID: 16358962
    [Abstract] [Full Text] [Related]

  • 3. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC, Kumar S, Krishnani N, Kumari N, Chourasia D, Tripathi S.
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 5. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB.
    World J Gastroenterol; 2004 Nov 01; 10(21):3146-50. PubMed ID: 15457561
    [Abstract] [Full Text] [Related]

  • 6. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
    Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, Valerín AL, Echandi G, Mena F, Brenes F, Yasuda N, Araki K, Sugiura T.
    Cancer Epidemiol Biomarkers Prev; 2007 Dec 01; 16(12):2631-6. PubMed ID: 18086767
    [Abstract] [Full Text] [Related]

  • 7. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S.
    Clin Gastroenterol Hepatol; 2008 Feb 01; 6(2):174-9. PubMed ID: 18237867
    [Abstract] [Full Text] [Related]

  • 8. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Feb 01; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 9. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M, Örmeci N, Erdal H, Keskin O, Karayel Z, Tutkak H, Soykan I.
    Clin Res Hepatol Gastroenterol; 2013 Jun 01; 37(3):302-11. PubMed ID: 23137754
    [Abstract] [Full Text] [Related]

  • 10. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI, Makarenko EV.
    Ter Arkh; 2008 Jun 01; 80(2):15-21. PubMed ID: 18372589
    [Abstract] [Full Text] [Related]

  • 11. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI, de Aretxabala U X, Santander D R, Sabah T S, Maira S J, Navarro R A, Planzer D M, Gómez L F, Etchart M, Gallegos I, Torrens X, Fasce P G, Reydet I.
    Rev Med Chil; 2007 Dec 01; 135(12):1519-25. PubMed ID: 18357351
    [Abstract] [Full Text] [Related]

  • 12. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.
    Pol Merkur Lekarski; 2008 Feb 01; 24(140):95-100. PubMed ID: 18634262
    [Abstract] [Full Text] [Related]

  • 13. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F.
    J Exp Clin Cancer Res; 2003 Sep 01; 22(3):371-8. PubMed ID: 14582693
    [Abstract] [Full Text] [Related]

  • 14. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
    Arista-Nasr J, Jiménez-Rosas F, Uribe-Uribe N, Herrera-Goepfert R, Lazos-Ochoa M.
    Am J Gastroenterol; 2001 Jun 01; 96(6):1746-50. PubMed ID: 11419824
    [Abstract] [Full Text] [Related]

  • 15. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb 01; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 16. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 01; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

  • 17. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Sep 01; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 18. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR, Cunha MP, Queiroz DM, Cruz FW, Guerra EJ, Mota RM, Braga LL.
    Digestion; 2008 Sep 01; 78(1):3-8. PubMed ID: 18689994
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1996 Aug 01; 5(8):627-30. PubMed ID: 8824365
    [Abstract] [Full Text] [Related]

  • 20. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep 01; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.